Form EFFECT Orexigen Therapeutics,
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | May 16, 2016 4:00 P.M. |
Form: | S-3 | ||||||
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackwell 3D Acquires Operating Dubai LLC, Inches Closer to Project Readiness
- Macatawa Bank Corporation Declares Quarterly Dividend
- White Plains New York Family Law Practice Eyes High Net Worth & Complex Divorces
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!